| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Galectin Therapeutics Inc. (GALT) have been net sellers, shedding 98,287 shares worth roughly $496K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. GALT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.61M | $19.37M | - | |
| CFO | 100.0K | $345.0K | - | |
| CEO | 100.0K | $345.0K | - | |
| Dir | 60.0K | $207.0K | - | |
| Dir | 60.0K | $207.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2018 | Czirr James C | Director | Sell | 244,444 | $5.43 | $1,328,289.80 | -3.7% | |
| Jan 26, 2018 | 10x Fund, L.P.85 | 10% Owner | Sell | 244,444 | $5.43 | $1,328,289.80 | -3.7% | |
| Dec 8, 2017 | Rubin Marc | Director | Buy | 7,000 | $1.85 | $12,971.70 | +14.4% | |
| Dec 7, 2017 | Freeman Kevin D | Director | Buy | 8,400 | $1.63 | $13,662.12 | +30.4% | |
| May 23, 2017 | Zucconi Theodore Daniel | Director | Buy | 1,000 | $2.27 | $2,270.00 | +1,205% | |
| Apr 20, 2016 | Czirr James C | Director | Sell | 44,312 | $1.67 | $74,138.30 | -0.7% | |
| Apr 20, 2016 | 10x Fund, L.P.85 | 10% Owner | Sell | 44,312 | $1.67 | $74,138.30 | -0.7% | |
| Jan 5, 2016 | Greenberg Arthur | Director | Buy | 1,666 | $1.72 | $2,865.52 | +1.5% | |
| Nov 30, 2015 | Amelio Gilbert F | Director | Sell | 100 | $2.10 | $210.00 | - | |
| Aug 12, 2015 | Traber Peter G59 | President &CEO | Buy | 2,000 | $2.00 | $4,000.00 | +1.9% |